Provided by Tiger Trade Technology Pte. Ltd.

Celldex Therapeutics

31.13
-0.6250-1.97%
Volume:50.05K
Turnover:1.56M
Market Cap:2.07B
PE:-7.98
High:31.75
Open:31.29
Low:30.85
Close:31.75
52wk High:34.52
52wk Low:14.40
Shares:66.45M
Float Shares:53.21M
Volume Ratio:0.38
T/O Rate:0.09%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.9000
EPS(LYR):-3.9000
ROE:-40.62%
ROA:-26.12%
PB:3.92
PE(LYR):-7.98

Loading ...

Nov 06, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2024

Major Issues Report

Form 8-K - Current report
Aug 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 09, 2024

Major Issues Report

Form 8-K - Current report
Jun 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 14, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jun 14, 2024

Major Issues Report

Form 8-K - Current report
Jun 07, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 07, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 31, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 31, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 31, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 31, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 06, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2024

Major Issues Report

Form 8-K - Current report
Mar 01, 2024

Major Issues Report

Form 8-K - Current report
Feb 26, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]